MADRIGAL PHARMACEUTICALS, INC. Increase (Decrease) in Other Accrued Liabilities
MADRIGAL PHARMACEUTICALS, INC. (MDGL) reported Increase (Decrease) in Other Accrued Liabilities of -$3.53 million for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-07-20.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccruedLiabilities · last filed 2016-07-20
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in other accrued liabilities for the quarter ending 2016-06-30 was -$1.38M, a 1237.19% decline year-over-year.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in other accrued liabilities for the quarter ending 2016-03-31 was -$2.15M.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in other accrued liabilities for the quarter ending 2015-12-31 was -$71.00K, a 106.00% decline year-over-year.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in other accrued liabilities for the quarter ending 2015-09-30 was -$482.00K.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in other accrued liabilities for fiscal 2015 was -$1.20M, a 361.66% decline from fiscal 2014.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in other accrued liabilities for fiscal 2014 was $459.00K, a 22.34% decline from fiscal 2013.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in other accrued liabilities for fiscal 2013 was $591.00K, a 10.88% increase from fiscal 2012.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in other accrued liabilities for fiscal 2012 was $533.00K, a 33.25% increase from fiscal 2011.
| Period end | Increase (Decrease) in Other Accrued Liabilities 3 month | Increase (Decrease) in Other Accrued Liabilities 6 month | Increase (Decrease) in Other Accrued Liabilities 9 month | Increase (Decrease) in Other Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2016-06-30 | -$1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-20 | -$3.53M 10-Q · filed 2016-07-20 | -$3.60M derived: sum of 3 quarters · filed 2016-07-20 | -$4.08M derived: sum of 4 quarters · filed 2016-07-20 |
| 2016-03-31 | -$2.15M 10-Q · filed 2016-05-10 | -$2.22M derived: sum of 2 quarters · filed 2016-05-10 | -$2.70M derived: sum of 3 quarters · filed 2016-05-10 | -$2.58M derived: sum of 4 quarters · filed 2016-07-20 |
| 2015-12-31 | -$71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | -$553.00K derived: sum of 2 quarters · filed 2016-03-15 | -$432.00K derived: sum of 3 quarters · filed 2016-07-20 | -$1.20M 10-K · filed 2016-03-15 |
| 2015-09-30 | -$482.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$361.00K derived: sum of 2 quarters · filed 2016-07-20 | -$1.13M 10-Q · filed 2015-11-05 | $53.00K derived: sum of 4 quarters · filed 2016-07-20 |
| 2015-06-30 | $121.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-20 | -$648.00K 10-Q · filed 2016-07-20 | $535.00K derived: sum of 3 quarters · filed 2016-07-20 | $317.00K derived: sum of 4 quarters · filed 2016-07-20 |
| 2015-03-31 | -$769.00K 10-Q · filed 2016-05-10 | $414.00K derived: sum of 2 quarters · filed 2016-05-10 | $196.00K derived: sum of 3 quarters · filed 2016-05-10 | $643.00K derived: sum of 4 quarters · filed 2016-05-10 |
| 2014-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $965.00K derived: sum of 2 quarters · filed 2016-03-15 | $1.41M derived: sum of 3 quarters · filed 2016-03-15 | $459.00K 10-K · filed 2016-03-15 |
| 2014-09-30 | -$218.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $229.00K derived: sum of 2 quarters · filed 2015-11-05 | -$724.00K 10-Q · filed 2015-11-05 | $497.00K derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-06-30 | $447.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$506.00K 10-Q · filed 2015-08-06 | $715.00K derived: sum of 3 quarters · filed 2016-03-15 | $1.59M derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-03-31 | -$953.00K 10-Q · filed 2015-05-07 | $268.00K derived: sum of 2 quarters · filed 2016-03-15 | $1.14M derived: sum of 3 quarters · filed 2016-03-15 | $1.93M derived: sum of 4 quarters · filed 2016-03-15 |
| 2013-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $2.09M derived: sum of 2 quarters · filed 2016-03-15 | $2.88M derived: sum of 3 quarters · filed 2016-03-15 | $591.00K 10-K · filed 2016-03-15 |
| 2013-09-30 | $873.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $1.66M derived: sum of 2 quarters · filed 2014-11-06 | -$630.00K 10-Q · filed 2014-11-06 | $854.00K derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-06-30 | $785.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | -$1.50M 10-Q · filed 2014-08-06 | -$19.00K derived: sum of 3 quarters · filed 2015-03-12 | $505.00K derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-03-31 | -$2.29M 10-Q · filed 2014-05-08 | -$804.00K derived: sum of 2 quarters · filed 2015-03-12 | -$280.00K derived: sum of 3 quarters · filed 2015-03-12 | $309.00K derived: sum of 4 quarters · filed 2015-03-12 |
| 2012-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $2.01M derived: sum of 2 quarters · filed 2015-03-12 | $2.60M derived: sum of 3 quarters · filed 2015-03-12 | $533.00K 10-K · filed 2015-03-12 |
| 2012-09-30 | $524.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04 | $1.11M derived: sum of 2 quarters · filed 2013-11-04 | -$951.00K 10-Q · filed 2013-11-04 | $394.00K derived: sum of 4 quarters · filed 2014-03-11 |
| 2012-06-30 | $589.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | -$1.48M 10-Q · filed 2013-08-01 | -$130.00K derived: sum of 3 quarters · filed 2014-03-11 | $210.00K derived: sum of 4 quarters · filed 2014-03-11 |
| 2012-03-31 | -$2.06M 10-Q · filed 2013-04-30 | -$719.00K derived: sum of 2 quarters · filed 2014-03-11 | -$379.00K derived: sum of 3 quarters · filed 2014-03-11 | $378.00K derived: sum of 4 quarters · filed 2014-03-11 |
| 2011-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $1.69M derived: sum of 2 quarters · filed 2014-03-11 | $2.44M derived: sum of 3 quarters · filed 2014-03-11 | $400.00K 10-K · filed 2014-03-11 |
| 2011-09-30 | $340.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $1.10M derived: sum of 2 quarters · filed 2012-11-06 | -$945.00K 10-Q · filed 2012-11-06 | -$64.00K derived: sum of 4 quarters · filed 2013-03-14 |
| 2011-06-30 | $757.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | -$1.28M 10-Q · filed 2012-08-02 | -$404.00K derived: sum of 3 quarters · filed 2013-03-14 | $107.00K derived: sum of 4 quarters · filed 2013-03-14 |
| 2011-03-31 | -$2.04M 10-Q · filed 2012-05-03 | -$1.16M derived: sum of 2 quarters · filed 2013-03-14 | -$650.00K derived: sum of 3 quarters · filed 2013-03-14 | |
| 2010-12-31 | $881.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $1.39M derived: sum of 2 quarters · filed 2013-03-14 | -$310.00K 10-K · filed 2013-03-14 | |
| 2010-09-30 | $511.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | -$1.19M 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | -$1.70M 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | $1.66M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |